PA
FTI icon

PharVision Advisers’s TechnipFMC FTI Stock Holding History

PharVision Advisers’s Portfolio FTI Stock Details FTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,483
Closed -$453K – 797
2025
Q3 		$453K Buy
11,483
+3,114
+37% +$114K 0.25% 40
2025
Q2 		$288K Sell
8,369
-360
-4% -$10.9K 0.41% 89
2025
Q1 		$277K Sell
8,729
-2,069
-19% -$62K 0.38% 111
2024
Q4 		$312K Buy
+10,798
New +$307K 0.26% 139

Other funds holding FTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's FTI Position: Q4 2025 in Review

PharVision Advisers sold out of TechnipFMC (FTI) in Q4 2025, closing a stake of 11,483 shares — an estimated $453K sold.

PharVision Advisers first reported a position in FTI in Q4 2024 and held it in 4 quarters. The position peaked at $453K in Q3 2025. 639 funds tracked by Wall St. Rank hold FTI as of Q4 2025.

  • PharVision Advisers reported no remaining TechnipFMC position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 11,483 TechnipFMC shares in Q4 2025, an estimated $453K.
  • PharVision Advisers first reported a position in TechnipFMC in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's TechnipFMC position peaked at $453K in Q3 2025.
  • 639 funds tracked by Wall St. Rank held TechnipFMC as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.